Julia Close

Julia Close, MD

Designated Institutional Official (DIO) & Associate Professor

Department: MD-HEMATOLOGY/ONCOLOGY
Business Phone: (352) 273-7832
Business Email: jclose@ufl.edu

About Julia Close

Julia Close, MD is a professor of medicine in the Division of Hematology and Oncology at the University of Florida. Her primary appointment is as the Associate Dean of Graduate Medical Education and the Designated Institutional Official (DIO) for the University of Florida College of Medicine. She was previously the Program Director for the Hematology/Oncology Fellowship Program.  She is a clinician educator, with research interest in curriculum related to general oncology and interactions with patients at the end of life. She is actively nationally in education, serving on the American Society of Clinical Oncology (ASCO)’s Professional Development Committee and the In-Training Exam Writing Committees for both Internal Medicine and Oncology.  She was previously Section Chief of Oncology at the Gainesville VAMC, and was the Assistant Chief of the Medical Service from 2015-2018. She previously chaired the VHA Oncology Field Advisory (FAC) Committee, a national committee providing guidance for national VA policy. She is interested in performance improvement in oncology, and has a national role in this through the VA FAC and through her membership on ASCO’s Workforce Advisory Group Committee.

Accomplishments

AAMC LEAD Certificate Program
2019 · American Association of Medical Colleges
Exemplary Teacher Award
2018 · UF College of Medicine
Excellence in Teaching Award
2017 · University of Florida
UF College of Medicine Society of Teaching Scholars Inductee
2017 · UF College of Medicine
Exemplary Teacher Award
2011-2016 · UF College of Medicine
Customer Service Key Award
2011 · UF Health
Excellence in Teaching Award
2011 · University of Florida
Excellence in Teaching Award
2010 · University of Florida

Teaching Profile

Courses Taught
2018
MDT7200 Elect Top/Medicine
2018
BMS6812 Intro Clin Med 2

Board Certifications

  • Hematology
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal Medicine
  • Medical Oncology
    American

Clinical Profile

Specialties
  • Cancer
  • Hematology
Areas of Interest
  • Adult soft tissue sarcoma
  • Bone tumor
  • Ewing sarcoma
  • Kaposi sarcoma
  • Leiomyosarcoma
  • Melanoma
  • Osteosarcoma
  • Rhabdomyosarcoma

Research Profile

Dr. Close’s research interest is in optimizing education for learners at all levels, with a focus on Graduate Medical Education, specifically fellows. She has developed both local and national curriculum. Local efforts include incorporating team based learning and virtual patients into the fellowship oncology curriculum. At a national level, she was one of 3 editors representing the American Society of Clinical Oncology (ASCO) in the development and improvement of a collaborative curriculum between the European Society for Medical Society (ESMO) and ASCO, to be used for oncology programs outside the United States. She is also interested in providing education to improve the physician and patient interaction at the end of life, and is currently pursuing research into this area. Finally, she is interested in preventing burn-out in physicians-in-training, and has recently worked with colleagues to expand the resiliency curriculum within the fellowship program.

Open Researcher and Contributor ID (ORCID)

0000-0002-7649-0320

Publications

2024
A point-of-care pilot randomized intervention to connect patients with cancer-induced financial toxicity to telehealth financial counseling.
Cancer causes & control : CCC. 35(3):393-403 [DOI] 10.1007/s10552-023-01794-9. [PMID] 37794203.
2023
Are evaluations in simulated medical encounters reliable among rater types? A comparison between standardized patient and outside observer ratings of OSCEs.
PEC innovation. 2 [DOI] 10.1016/j.pecinn.2023.100125. [PMID] 37214504.
2023
Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncology.
JNCI cancer spectrum. 7(1) [DOI] 10.1093/jncics/pkac081. [PMID] 36416149.
2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41(25):4154-4163 [DOI] 10.1200/JCO.23.00402. [PMID] 37467452.
2022
A Multicentered Academic Medical Center Experience of a Simulated Root Cause Analysis (RCA) for Hematology/Oncology Fellows.
Journal of cancer education : the official journal of the American Association for Cancer Education. 37(4):911-914 [DOI] 10.1007/s13187-020-01899-8. [PMID] 33057958.
2022
Comparing Transactional eHealth Literacy of Individuals With Cancer and Surrogate Information Seekers: Mixed Methods Study
JMIR Formative Research. 6(9) [DOI] 10.2196/36714. [PMID] 36170007.
2022
Incidence, Nature, and Consequences of Oncologists’ Experiences With Sexual Harassment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(11):1186-1195 [DOI] 10.1200/JCO.21.02574. [PMID] 35089804.
2021
Satisfaction of General Versus Specialized Continuity Clinic in Hematology Oncology Fellowship Training: A Survey.
Journal of medical education and curricular development. 8 [DOI] 10.1177/23821205211025870. [PMID] 34616913.
2021
Skills-Based Programs Used to Reduce Physician Burnout in Graduate Medical Education: A Systematic Review.
Journal of graduate medical education. 13(4):471-489 [DOI] 10.4300/JGME-D-20-01433.1. [PMID] 34434508.
2020
Addressing bias towards patients with sickle cell disease.
The Lancet. Haematology. 7(7) [DOI] 10.1016/S2352-3026(20)30183-6. [PMID] 32589975.
2020
ASCO Voices 2020.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38(27):3231-3232 [DOI] 10.1200/JCO.20.01584. [PMID] 32772763.
2019
Application of an objective structured clinical examination to evaluate and monitor intern’s proficiency of hand hygiene and personal protective equipment use in the United States.
Journal of educational evaluation for health professions. 16 [DOI] 10.3352/jeehp.2019.16.31. [PMID] 31614408.
2019
In Memory of the Maple Syrup Man.
The oncologist. 24(9):1285-1286 [DOI] 10.1634/theoncologist.2018-0612. [PMID] 30926676.
2019
Preparing Fellows for Graduation: Perspectives on Career Guidance.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 39:609-614 [DOI] 10.1200/EDBK_242603. [PMID] 31099656.
2019
Preparing Hematology/Oncology Fellows for an Entry into Practice
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2018
Caring for Colleagues and Loved Ones With Cancer.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 38:903-908 [DOI] 10.1200/EDBK_201451. [PMID] 30231376.
2018
Impact of Closed Facebook Group Participation on Female Hematology/Oncology Physicians.
Journal of oncology practice. 14(12):e758-e769 [DOI] 10.1200/JOP.18.00448. [PMID] 30537459.
2017
Implementation of a mock root cause analysis to provide simulated patient safety training.
BMJ open quality. 6(2) [DOI] 10.1136/bmjoq-2017-000096. [PMID] 29450282.
2017
Infusion Room-Based Transition to Practice Model for Teaching Cancer Systemic Therapy Management.
Journal of oncology practice. 13(11):e909-e915 [DOI] 10.1200/JOP.2017.023549. [PMID] 28885879.
2016
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.
ESMO open. 1(5) [PMID] 27843641.
2016
Perspectives on death and dying: a study of resident comfort with End-of-life care.
BMC medical education. 16(1) [PMID] 27871287.
2014
Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.
The American journal of the medical sciences. 347(3):254-5 [DOI] 10.1097/MAJ.0000000000000228. [PMID] 24553361.
2014
Fellowship engagement in hematology/oncology professionalism training.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(11):1164-6 [DOI] 10.1200/JCO.2013.54.6879. [PMID] 24590646.
2010
Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment.
The journal of supportive oncology. 8(2):72-7 [PMID] 20464886.
2009
Effectiveness of Imatinib Therapy for a Patient With Sickle Cell Anemia and Chronic Myelocytic Leukemia.
Blood. 114:1004-1005
2009
Impact of An Annual Hematology/Oncology Fellow Wet Laboratory Program On Fund of Biomedical Knowledge
Blood. 114

Grants

Jan 2021 ACTIVE
A multicenter phase II trial of paclitaxel with and without nivolumab in taxane na?ve, and nivolumab and cabozantinib in taxane pretreated subjects with angiosarcoma
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU via BRISTOL MYERS SQUIBB CO
Jan 2021 ACTIVE
A multicenter phase II trial of paclitaxel with and without nivolumab in taxane na?ve, and nivolumab and cabozantinib in taxane pretreated subjects with angiosarcoma
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU via EXELIXIS
Jan 2021 ACTIVE
A MULTICENTER PHASE II TRIAL OF PACLITAXEL WITH AND WITHOUT NIVOLUMAB IN TAXANE NA?VE, AND NIVOLUMAB AND CABOZANTINIB IN TAXANE PRETREATED SUBJECTS WITH ANGIOSARCOMA
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
Jul 2019 – Mar 2022
Addressing Health Care Disparity in Patients with Sickle Cell Disease Through an Integrated Implicit Bias Curriculum for Internal Medicine Housestaff
Role: Principal Investigator
Funding: Alliance for Academic Internal Medicine

Education

Fellowship – Hematology and Oncology
2005-2008 · University of Florida
Chief Medical Resident
2004-2005 · University of Florida
Residency
2001-2004 · University of Florida, Department of Medicine
Medical Degree
1997-2001 · University of Florida, College of Medicine

Contact Details

Phones:
Business:
(352) 273-7832
Emails:
Business:
jclose@ufl.edu
Addresses:
Business Mailing:
PO Box 100321
GAINESVILLE FL 32610